about
Participation in research bronchoscopy: a literature reviewRespiratory symptoms in adults are related to impaired quality of life, regardless of asthma and COPD: results from the European community respiratory health surveyInflammatory cytokine response to exercise in alpha-1-antitrypsin deficient COPD patients 'on' or 'off' augmentation therapy.Adult attention deficit hyperactivity disorder is associated with asthma.Chronic obstructive pulmonary disease is associated with low levels of vitamin D.Comparison of inflammatory markers in induced and spontaneous sputum in a cohort of COPD patients.Productivity losses in chronic obstructive pulmonary disease: a population-based survey.Expert opinion of mediastinal lymph node positions from an intrabronchial viewThe incidence of adult asthma: a review.The Bergen COPD microbiome study (MicroCOPD): rationale, design, and initial experiencesTNF-α is associated with loss of lean body mass only in already cachectic COPD patientsIncidence of utilization- and symptom-defined COPD exacerbations in hospital- and population-recruited patientsComparing microbiota profiles in induced and spontaneous sputum samples in COPD patients.Antimicrobial peptide levels are linked to airway inflammation, bacterial colonisation and exacerbations in chronic obstructive pulmonary disease.The association of tidal EFL with exercise performance, exacerbations, and death in COPDProtected sampling is preferable in bronchoscopic studies of the airway microbiomeA pilot study of hot-wire, ultrasonic and wedge-bellows spirometer inter- and intra-variability.Comorbidity of asthma with ADHD.Paraneoplastic Hu and CRMP5 antibodies are present in smokers without cancer or neurological disease.Median regression spline modeling of longitudinal FEV1 measurements in cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD) patients.Growth differentiation factor-15 is a predictor of important disease outcomes in patients with COPD.Self-reported influenza vaccination and protective serum antibody titers in a cohort of COPD patients.Reference values for within-breath pulmonary impedance parameters in asymptomatic elderly.Associations between obstructive lung disease and symptoms of obstructive sleep apnoea in a general population.Variability of within-breath reactance in COPD patients and its association with dyspnoea.Predictors for PaO2 and hypoxemic respiratory failure in COPD-A three-year follow-up.Recommendations for epidemiological studies on COPDComparison of 2011 and 2007 Global Initiative for Chronic Obstructive Lung Disease Guidelines for Predicting Mortality and HospitalizationAssociation of exposure to environmental tobacco smoke in childhood with chronic obstructive pulmonary disease and respiratory symptoms in adultsBody composition and plasma levels of inflammatory biomarkers in COPD[Mortality after hospitalization for obstructive lung disease][Hospital admissions due to obstructive lung diseases and pneumonia in two hospital districts]Bias in retrospective studies of trends in asthma incidenceExposure to environmental tobacco smoke in a general populationCost minimization analysis for combinations of sampling techniques in bronchoscopy of endobronchial lesionsA randomised trial of endobronchial ultrasound guided sampling in peripheral lung lesionsSystemic inflammatory markers in COPD: results from the Bergen COPD Cohort StudyOccupational exposure and incidence of respiratory disorders in a general populationExplained variance for blood gases in a population with COPDSystemic mannose-binding lectin is not associated with Chronic Obstructive Pulmonary Disease
P50
Q26768846-1E5A9F4F-09C5-4872-82FB-9EA08682AA62Q30496983-D91EC772-7349-483A-875A-578B949697B0Q33880491-60B58658-2FD6-41FB-8BA9-F568CE8183A1Q33984093-51FF8EF4-4FA6-4398-A115-F9AE176F88C3Q34318385-CC41591B-70CF-4D7A-BA40-4CC444A7A2C1Q34543991-5D21BF51-A1BD-4D9C-A81B-405F914E0312Q34635458-3E804552-CF59-4419-A875-3A7DE9C9DC35Q35902023-FEDCA19C-6C57-4302-ADEE-D55C67104A74Q36170954-492B8C14-0398-431B-8367-F0AC7AD4E13DQ36239289-514CD44D-F2B0-4A26-92E7-6464F66297C9Q36367744-3A2B5BC7-A73F-4954-9E70-142F5A0654D4Q37242230-E59685FA-287F-4169-9CAA-BD61029BFE2FQ38603379-B44BD433-2F77-45CC-BC03-AFB67E319455Q40292658-435BD4A2-3DE6-4E85-9681-BF4E6CC823DDQ41185075-0A87D902-6C30-427F-9DCC-5FC15AA52C77Q41557420-44AA95DB-6A86-42CD-938C-87D09A12075AQ42374095-ACE3E300-95FB-469D-96C5-346955D789BDQ44498724-7E14AF71-7F64-436A-94BC-7F52D9CC810EQ44664000-272A35D4-A759-4CD3-8930-067434AE8287Q47275872-56C8059D-0264-444E-8F11-1C95A14DAD49Q48120324-5B94FFB1-BA24-418C-9375-1D2C9B16ABE9Q50639991-6A2ABFF9-C7C3-4857-AFAE-163B9670E728Q51341314-0C15AF53-A410-4C7F-822D-13A19C1664F5Q51541860-21026889-DCFC-425C-8437-07F009B74149Q51687272-12BBA516-4B4B-4376-A8B4-29DC714F1684Q51723420-375978F1-B6A0-4388-A6CB-3D01B9143252Q57955761-151CC43E-1FFB-4068-967A-530076ABB74EQ58840323-E629512C-E28B-464B-B8E0-13A34D901266Q58840333-8D677D31-3355-4390-A8DD-E29B425F69CFQ58840336-7563043C-D529-44BF-B825-5599E43BA8BCQ73264956-7F599183-4267-413D-A2B3-DBD046F7897DQ73432599-8D327B19-B80B-489A-A525-A337C92AB963Q76379411-E55700AB-1944-46D9-9C3A-945744CBDAB2Q79824904-B50EB650-44BA-4A87-B5CB-B295E1A19001Q83263122-720331E9-269F-4B3A-9F89-96FBD6FA5A5CQ83826864-68F14BEC-5A8C-4C25-995D-CC0004EA782CQ84323166-5EC2E806-13CF-4780-A29F-602DABD3CF89Q84637586-C3CEB57C-4CD7-4352-A7AE-F27371442050Q84666354-26744AF0-F1C4-46C6-803E-2954CB01AA31Q84738653-692C490B-7E56-4FC0-A8F1-45C3B4A6079E
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Tomas M Eagan
@ast
Tomas M Eagan
@en
Tomas M Eagan
@es
Tomas M Eagan
@nl
type
label
Tomas M Eagan
@ast
Tomas M Eagan
@en
Tomas M Eagan
@es
Tomas M Eagan
@nl
prefLabel
Tomas M Eagan
@ast
Tomas M Eagan
@en
Tomas M Eagan
@es
Tomas M Eagan
@nl
P106
P21
P31
P496
0000-0001-8725-9960